Document Detail


Tadalafil in the management of severe pulmonary artery hypertension.
MedLine Citation:
PMID:  18984932     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Severe oyknibart arterial hypertension is a life-threatening disease with a poor prognosis. Continuous intravenous infusion of prostacyclin has proved effective in this condition. However, it carries the risk of serious complications arising from the complex delivery system along with a high cost. Prostacyclin analogs, endothelin antagonists, and the phophodiesterase-5 inhibitor sildenafil are emerging and promisinge therapies. Tadalafil, like sildenafil, is a selective phosphodiesterase-5 inhibitor with a longer duration of action. We repport the use of tadalafil in two patients of severe pulmonary arterial hypertension who could not afford expensive treatment.
Authors:
Thokchom Sd Singh; Dilip Kumar; Soumik Basu; Manotosh Panja; Bishwanath Mitra
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian heart journal     Volume:  58     ISSN:  0019-4832     ISO Abbreviation:  Indian Heart J     Publication Date:    2006 Jan-Feb
Date Detail:
Created Date:  2008-11-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0374675     Medline TA:  Indian Heart J     Country:  India    
Other Details:
Languages:  eng     Pagination:  52-3     Citation Subset:  IM    
Affiliation:
Department of Medicine and Cardiology, Regional Institute of Medical Sciences, Imphal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Smoking cessation in patients with acute coronary syndrome.
Next Document:  Total anomalous pulmonary venous connection to azygos vein: echocardiographic recognition of a rare ...